Clinique D

Clinique D is the leading cosmetic dermatology clinic on Montreal’s North Shore. It is also the reference medical phototherapy center serving the regions of Laval, the North Crown, and the northern part of the Island of Montreal. Please note that phototherapy is a service covered by the RAMQ. Its warm staff, minimalist décor, and state-of-the-art systems come together to provide high-quality dermatological care with a human and efficient approach.

Our Team

Dre Danielle Brassard

Dr. Danielle Brassard

Dermatologist

Following the completion of her medical degree at Université Laval in 2007, Dr. Danielle Brassard pursued specialized studies in dermatology at the Université de Montréal Faculty of Medicine. Subsequently, she earned admission to the Royal College of Physicians and Surgeons of Canada in 2013. Dr. Brassard has accumulated a wealth of experience, practicing in diverse locations, including Cornwall (Ontario), Joliette (Quebec), and Hôpital du Sacré-Cœur de Montréal, prior to establishing Clinique D in Laval in 2015.

Recognized as an esteemed authority in aesthetic dermatology, encompassing fillers, Botox®, laser procedures, phototherapy, skin cancer surgery, and biological therapy for conditions such as psoriasis, atopic dermatitis, and hidradenitis suppurativa, Dr. Brassard is actively engaged in research endeavors in these domains. Serving as a principal researcher with over six years of experience in observational studies, she is presently involved in randomized controlled trials evaluating novel products.

Certified by the Royal College of Physicians and Surgeons of Canada, Dr. Brassard has been leveraging her profound anatomical knowledge as a practicing dermatologist since 2015. She is frequently sought after for consultations and is cited in both media and legal contexts as a foremost expert in aesthetic procedures. Additionally, she contributes to the dissemination of knowledge through seminars and lectures on therapeutic approaches for acne, chronic hand eczema, hidradenitis suppurativa, psoriasis, and rosacea.

Her expertise and reputation in aesthetic medicine, combined with the growing demand for training among nurses, physicians, and more recently, dentists, led to the creation of The Centre of Excellence in Aesthetic Medicine (CEME). Dr. Brassard serves as both trainer and mentor to healthcare professionals seeking to master injection techniques for neuromodulators (Botox®, Xeomin®, Dysport®) and dermal fillers (Juvéderm®, Restylane®, Belotero®, Radiesse®, Belkyra®). She offers a training program that is personalized, rigorous, and focused on hands-on practice. Her teaching approach—both human and structured—attracts professionals eager to deepen their clinical expertise and expand their scope of practice in aesthetic medicine.

    Dr. Camille Loranger

    Dermatologist

    Dr. Loranger graduated from the University of Sherbrooke in 2013 and did her specialization in dermatology at McGill University. She was admitted to the Royal College of Physicians and Surgeons of Canada in 2018. Dr. Loranger is now a part-time member of the Clinique D team.

      Dora - Clinique D

      Dora

      Director
      France - Clinique D

      France

       Nurse Trainer
      Sarah - Clinique D

      Sarah

      Laser Technician
      Vickie - Clinique D

      Vickie

       Laser Technician
      Arielle - Clinique D

      Arielle

      Laser Technician
      Mayra - Clinique D

      Mayra

       Clinical Nurse
      Isabelle - Clinique D

      Isabelle

      Customer Service
       
      Élodie - Clinique D

      Élodie

       Phototherapy Technician

       

      Clinic Philosophy

      Our experts are committed to meeting customer expectations while preserving the integrity and natural beauty of each individual. Our procedures are carried out with finesse and precision, with the aim of enhancing existing beauty without altering it.


      In addition, the clinic's atmosphere is one of serenity, well-being and luxurious tranquility. The aim is to create an atmosphere conducive to confidence and well-being, fostering a positive and pleasant experience.


       

       
      Privacy Officer
      Mrs Dora Filippou
      Director
      Tel.: 450 239-6285 ext. 225
      Email: [email protected]

       

      Press Reviews

      Théorie TikTok: Accutane peut-il vraiment faire rétrécir le nez, comme le prétend Kendall Jenner?

      Read More
      « Microneedling » à la maison : la mode TikTok qui laisse des marques

      Read More
      Un meilleur encadrement réclamé pour le micro-aiguillage

      Read More
      Avertissement de la FDA: appel à un encadrement médical rigoureux pour certains soins esthétiques

      Read More
      «Skincare»: comment bien prendre soin de la peau de nos seins?

      Read More
      ESI Conference

      Read More
      La K-Beauty est là pour de bon

      Read More
      Clinique D on design blog Leibal

      Read More
      Health and design, a prefect match – Clinique D on Kollectif.net

      Read More
      Clinique D featured on Hong-Kong’s Gooood

      Read More
      Light clinic: Clinique D profile on Domus

      Read More
      Clinique D featured on AIT (in German)

      Read More

      Scientific Publications

      Disease Burden in a Cohort of Canadian Adults With Moderate-to-Severe Atopic Dermatitis by Systemic Therapy Use.

      J Cutan Med Surg. 2026 Mar 26:12034754261431744. doi: 10.1177/12034754261431744. Epub ahead of print. PMID: 41885181. Gooderham MJ, Breslavets M, Turchin I, Loo WJ, Gagné-Henley A, Brassard D, Sancho C, Chen SH, Labelle M, Préfontaine D, Lynde CW.

      Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.

      Arch Dermatol Res. 2024 Jun 8;316(7):362. doi: 10.1007/s00403-024-03122-w. PMID: 38850346; PMCID: PMC11162361. Papp KA, Gooderham M, Lynde C, Brassard D, Al-Mohammedi F, Prajapati VH, Delorme I, Albrecht L, Haydey R, Alam MS, Beecker J, Siddha S, Maguin M, Farag MS, Vieira A, Rihakova L, Langley RG.

      Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.

      Dermatol Ther (Heidelb). 2023 Feb;13(2):535-553. doi: 10.1007/s13555-022-00870-3. Epub 2022 Dec 23. PMID: 36562944; PMCID: PMC9782282. Gooderham M, Papp KA, Lynde C, Delorme I, Beecker J, Albrecht L, Dei-Cas I, Brassard D, Prajapati VH, Vieira A, Rihakova L.

      Physician survey regarding patient nonattendance at follow-up appointments at a university-affiliated medical dermatology clinic.

      J Cutan Med Surg. 2012 Mar-Apr;16(2):92-6. doi: 10.2310/7750.2011.11004. PMID: 22513060. Nasseri E, Bertrand J, Brassard D, Fortier-Riberdy G, Marcil I.

      Inverse psoriasis and hyperhidrosis of the axillae responding to botulinum toxin type A.

      Arch Dermatol. 2011 May;147(5):629-30. doi: 10.1001/archdermatol.2011.111. PMID: 21576592. Saber M, Brassard D, Benohanian A.

      Real-world effectiveness, retention and updosing of secukinumab in biologic-naive and experienced patients with moderate-to-severe plaque psoriasis: PURE registry data.

      ePoster at the 100th CDA Annual Conference. June 18-21. Halifax, Nova Scotia. Gooderham, M.; Albrecht L.; Beecker, J. et al.

      Real-World Effectiveness of Brodalumab in Canadian Patients with Plaque Psoriasis: CARE Study 6-Month Interim.

      ePoster at the 100th CDA Annual Conference. June 18-21. Halifax, Nova Scotia. Sunil, K.; Brassard, D.; Adam, D.N. et all.

      Effectiveness and safety of upadacitinib in Canadian adult patients with atopic dermatitis who were inadequate responders or intolerant to dupilumab: Results from the CAN UpTIMISE phase 4 multicentre study.

      Abstract for RAD June 2025. H. Chih-ho Hong et all.

      Effectiveness and Safety of Brodalumab in Patients with Plaque Psoriasis with and without Psoriatic Arthritis in the Canadian Real-World Setting: 6-Month Follow-up Interim Results from the CARE Study”.

      EADV 2024. Brassard, D.; Breslavets, M.; Cullingham, K. et al.

      Baseline Demographic and Clinical Characteristics of Patients with Plaque Psoriasis treated with Brodalumab in the Canadian Real-World Setting: Results from the CARE Study.

      ISPOR Europe 2023. Kalia, S.; Wiseman, M.C.; Loo, W.J.; et al.

      Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.

      Dermatol Ther (Heidelb) 13, 535–553 (2023). Gooderham, M.; Papp, K.A.; Lynde, C. et al.

      Secukinumab treatment shows effectiveness in the treatment of different body regions in patients with moderate-to-severe psoriasis: 36-month results from the PURE study.

      Poster presented at the European Academy of Dermatology and Venereology Annual Meeting, on 28 Oct-02 Nov 2021. Brassard, D.; Papp, K.A.; Albrecht, L. et al.

      Secukinumab Shows Sustained Effectiveness and Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis over 36 Months: Data from the PURE Registry.

      Poster presented at the European Academy of Dermatology and Venereology Annual Meeting, (Virtual meeting) on 29 Oct-01 Nov 2020. Papp, K.A.; Gooderham, M.; Lynde, C. et al.

      Secukinumab Demonstrates Sustained Effectiveness and Safety in Patients with Moderate-to-Severe Plaque Psoriasis: 30-month Follow-up Data from the PURE Registry.

      Poster presented at the American Academy of Dermatology Annual Meeting, Denver, USA, on 20-24 Mar 2020. Papp, K.A.; Gooderham, M.; Haydey R. et al.

      Secukinumab Treatment Results in Improvement of Disease Characteristics in Patients with Moderate to Severe Psoriasis: 24 Month Follow-up Data from the PURE Registry.

      Poster presented at the Simposio de Residentes de Dermatología del Hospital General San Juan De Dios, Pasay City. Phillipines, on 20 Sep 2019. Papp, K.A.; Gooderham, M.; Alavi, A. et al.

      Secukinumab Treatment Results in Improvement of Disease Characteristics in Patients with Moderate to Severe Psoriasis: 24 Month Follow-up Data from the PURE Registry.

      Poster presented at the Canadian Dermatology Association Annual Congress, Calgary, Alberta, Canada, on 27-30 Jun 2019. Papp, K.A.; Gooderham, M.; Alavi, A. et al.

      Secukinumab Treatment Results in Improvement of Disease Characteristics in Patients with Moderate to Severe Psoriasis: 24 Month Follow-up Data from the PURE Registry.

      Poster presented at the 24th World Congress of Dermatology, Milan, Italy, on 10-15 Jun 2019. Papp, K.A.; Gooderham, M.; Alavi, A. et al.

      Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.

      J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16. PMID: 33075408; PMCID: PMC7566694. Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group.

      Make an appointment

        We are accepting requests for cosmetic dermatology and for medical phototherapy covered by the RAMQ (for existing patients or with a referral from your treating dermatologist).
        We are accepting requests for medical phototherapy covered by the RAMQ (for existing patients or with a referral from your treating dermatologist).
        We are accepting requests for cosmetic dermatology.

        Important Notice:
        Clinique D specializes exclusively in phototherapy and aesthetic dermatology. Therefore, we are unable to offer an appointment for the service you are requesting. To obtain the full list of dermatologists who offer this service, please consult the website of the Quebec Association of Dermatology Specialists: www.dermato.qc.org.

        Please note:
        Except for phototherapy (which requires a referral from a dermatologist), Dr. Brassard is no longer accepting new patients under the public health system (RAMQ).







        NOTE: To book a phototherapy appointment, you must include a referral from your treating dermatologist (Accepted formats: PDF, JPEG, JPG, PNG, GIF. Limit: 5mb)


        Fees apply for this procedure, as it is not covered by the RAMQ.


        Cancelation Policy: If you miss an appointment or cancel with less than 24 hours notice you will have to pay a $50 fee.

        Clinique D

        1150 boulevard de l’Avenir, office 300 & 320,
        Laval, Quebec H7N 6L2

        Opening hours

        Monday to Friday 8AM to 5PM
        Phototherapy : Monday to Friday 7AM to 7PM

        Clinique D

        1150 boulevard de l’Avenir, office 300 & 320,
        Laval, Quebec H7N 6L2

        Opening hours

        Monday to Friday 8AM to 5PM
        Phototherapy : Monday to Friday 7AM to 7PM